Royal Society elects Melina Schuh as Fellow

May 27, 2026

Biochemist Melina Schuh, currently Managing Director at the Max Planck Institute (MPI) for Multidisciplinary Sciences, has been elected as a Fellow of the British Royal Society in recognition of her outstanding contributions to oocyte research.

In today’s society, couples often wait until later in life to have children. However, this delay is not without risks: Female fertility declines with age. The most common cause of this decline is errors during meiosis. In this process, the egg cell halves its set of chromosomes, which is prone to errors. “If the chromosome pairs are not separated correctly during meiosis, the mature egg may end up with too many or too few chromosomes,” Schuh explains. “If such an egg is fertilized, it can affect the course of the pregnancy and the child’s health, and lead to miscarriages or infertility.”

Melina Schuh and her team are investigating how errors occur when the set of chromosomes is halved. The researchers have shown that chromosomes are often not correctly bound to the cellular machinery that separates the chromosome pairs. They also discovered that the chromosomes in egg cells become unstable as women age. These factors, along with others identified by her team, contribute to the error-prone nature of meiosis and can result in mature egg cells containing an incorrect number of chromosomes. Schuh’s research findings could help women in their late 30s and early 40s fulfill their desire to have children in the future and also improve the success rates of in vitro fertilization. 

The Royal Society elects the most distinguished scientists, engineers, and technology experts to its Fellowship. Schuh is one of over 90 researchers worldwide who will hold the title “FRS” (“Fellow of the Royal Society”) in 2026.  “Our fellowship is strengthened not only by individual distinction, but by the diversity of perspectives and experiences its members bring”, said Royal Society President Sir Paul Nurse. “The new fellows underscore the truly international character of modern science. This aspect plays a crucial role in achieving breakthroughs that benefit us all.”

In addition to Melina Schuh, four other Max Planck directors were elected to the Royal Society this year: Ramin Golestanian of the MPI for Dynamics and Self-Organization, Gilles Laurent of the MPI for Brain Research, Ruth Ley of the MPI for Biology and Sami K. Solanki of the MPI for Solar System Research. (vl)

About Melina Schuh
Melina Schuh studied biochemistry at the University of Bayreuth, conducted research at the European Molecular Biology Laboratory (EMBL) in Heidelberg, and received her PhD from the University of Heidelberg in 2008. She then moved to Cambridge (United Kingdom), where she served as a group leader at the MRC Laboratory of Molecular Biology from 2009 until the end of 2015. Since January 2016, she has been a director at the MPI for Multidisciplinary Sciences, where she heads the Department of Meiosis. In 2023, the University of Göttingen appointed her as an honorary professor. She has received numerous awards for her work, including the Gottfried Wilhelm Leibniz Prize from the German Research Foundation, the EMBO Gold Medal, the Colworth Medal from the Biochemical Society, the Science Breakthrough 2025 from the Falling Walls Foundation, and the Carus Medal from the German National Academy of Sciences Leopoldina, of which she has been a member since 2019.
 
About the Royal Society and its Fellowships
Founded in 1660, the Royal Society is the world’s oldest continuously existing academy of sciences. Its primary purpose is to recognize, promote, and support scientific excellence, as well as to advance the development and application of science for the benefit of humanity. Members are elected for life and are known as Fellows of the Royal Society (FRS for short). In total, the Royal Society has over 8,000 members. Among its former members are some of the most famous names in the history of science, including Isaac Newton, Charles Darwin, Albert Einstein, and Lise Meitner.

Other Interesting Articles

Go to Editor View